BUZZ-Argus 将 Solventum 的评级上调至 "买入 "后，该公司股价上涨

路透中文

Jul 01

BUZZ-Argus 将 <a href="https://laohu8.com/S/SOLV">Solventum</a> 的评级上调至 "买入 "后，该公司股价上涨

7月1日 - ** 医疗设备制造商Solventum的SOLV.N股价上涨约2.6%至77.82美元

** Argus Research将圣万提公司的评级从 "持有 "上调至 "买入"。

** 券商称SOLV转型为增长更快、利润率更高的业务模式

** 阿格斯将SOLV公司2026年调整后每股收益预期从5.95美元上调至5.98美元

** 13家券商中有4家将SOLV评为 "买入 "或更高评级，8家为 "持有"，1家为 "卖出"；PT中值为85美元--LSEG数据

** 包括本交易日的走势在内，该股今年累计上涨约 17.3

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2548885358"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548885358\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2548885358?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-07-01 23:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548885358","market":"us","top_or_hot":-1,"title":"BUZZ-Argus 将 Solventum 的评级上调至 \"买入 \"后，该公司股价上涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Argus 将 <a href=\"https://laohu8.com/S/SOLV\">Solventum</a> 的评级上调至 \"买入 \"后，该公司股价上涨</title></head><body><p><span>7月1日</span><span> - </span> ** 医疗设备制造商Solventum的<span>SOLV.N</span>股价上涨约2.6%至77.82美元</p><p> ** Argus Research<span>将圣万提公司的评级 </span>从 \"持有 \"<span>上调 </span>至 \"买入\"。</p><p> ** 券商称SOLV转型为增长更快、利润率更高的业务模式</p><p> ** 阿格斯将SOLV公司2026年调整后每股收益预期从5.95美元上调至5.98美元</p><p> ** 13家券商中有4家将SOLV评为 \"买入 \"或更高评级，8家为 \"持有\"，1家为 \"卖出\"；PT中值为85美元--LSEG数据</p><p> *<span>* 包括本交易日的走势在内</span>，该股今年累计上涨约 17.3</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Argus 将 Solventum 的评级上调至 \"买入 \"后，该公司股价上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Argus 将 Solventum 的评级上调至 \"买入 \"后，该公司股价上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2025-07-01 23:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Argus 将 <a href=\"https://laohu8.com/S/SOLV\">Solventum</a> 的评级上调至 \"买入 \"后，该公司股价上涨</title></head><body><p><span>7月1日</span><span> - </span> ** 医疗设备制造商Solventum的<span>SOLV.N</span>股价上涨约2.6%至77.82美元</p><p> ** Argus Research<span>将圣万提公司的评级 </span>从 \"持有 \"<span>上调 </span>至 \"买入\"。</p><p> ** 券商称SOLV转型为增长更快、利润率更高的业务模式</p><p> ** 阿格斯将SOLV公司2026年调整后每股收益预期从5.95美元上调至5.98美元</p><p> ** 13家券商中有4家将SOLV评为 \"买入 \"或更高评级，8家为 \"持有\"，1家为 \"卖出\"；PT中值为85美元--LSEG数据</p><p> *<span>* 包括本交易日的走势在内</span>，该股今年累计上涨约 17.3</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SOLV","symbol_name":"Solventum","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nL4S3SY16R:1","article_id":"2548885358","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548885358","pubTimestamp":1751382108,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Argus 将 Solventum 的评级上调至 \"买入 \"后，该公司股价上涨7月1日 -  ** 医疗设备制造商Solventum的SOLV.N股价上涨约2.6%至77.82美元 ** Argus Research将圣万提公司的评级 从 \"持有 \"上调 至 \"买入\"。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"SOLV":"Solventum"},"translate_title":"Solventum stock rises after BUZZ-Argus upgrades it to \"buy\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SOLV":0.9},"content_text":"BUZZ-Argus 将 Solventum 的评级上调至 \"买入 \"后，该公司股价上涨7月1日 -  ** 医疗设备制造商Solventum的SOLV.N股价上涨约2.6%至77.82美元 ** Argus Research将圣万提公司的评级 从 \"持有 \"上调 至 \"买入\"。 ** 券商称SOLV转型为增长更快、利润率更高的业务模式 ** 阿格斯将SOLV公司2026年调整后每股收益预期从5.95美元上调至5.98美元 ** 13家券商中有4家将SOLV评为 \"买入 \"或更高评级，8家为 \"持有\"，1家为 \"卖出\"；PT中值为85美元--LSEG数据 ** 包括本交易日的走势在内，该股今年累计上涨约 17.3(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}